EichorEICHOR
Location: Utrecht Synced from ClinicalTrials.gov · August 08, 2026

Clinical studies recruiting near Utrecht

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Combination of Chemotherapy and Adaptive MR-Guided Radiotherapy to Improve Outcomes in Patients With Esophageal Adenocar
Phase 1 · University Medical Center Utrecht · UMC Utrecht · NCT07359443International Leukemia Target Board
Phase N/A · Princess Máxima Center for Pediatric Oncology · Princess Maxima Center for Pediatric Oncology · NCT05270096A Global Study of Novel Agents in Paediatric and Adolescent Relapsed and Refractory B-cell Non-Hodgkin Lymphoma
Phase 2/Phase 3 · Princess Máxima Centre for Pediatric Oncology · University of Birmingham · NCT05991388Interfant-21 Treatment Protocol for Infants Under 1 Year With KMT2A-rearranged ALL or Mixed Phenotype Acute Leukemia
Phase 3 · Princess Máxima Center for pediatric oncology · Princess Maxima Center for Pediatric Oncology · NCT05327894This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in
Phase 3 · St. Antonius Ziekenhuis, locatie Utrecht · Pfizer · NCT06758401The Prevention of Systemic Ectopic Mineralization in Pseudoxanthoma Elasticum
Phase 3 · University Medical Center Utrecht · UMC Utrecht · NCT05832580The DRAGON 2 Trial
NA · Universitair Medisch Centrum Utrecht · Maastricht University · NCT05428735Spectral Cancer Tissue Recognition - I
Phase N/A · UMC Utrecht · SPCTR · NCT07459062A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carbop
Phase 3 · Hoffmann-La Roche · NCT06793215UCAN CAN-DU: Canada-Netherlands Personalized Medicine Network in Childhood Arthritis and Rheumatic Disease
Phase N/A · Wilhelmina Children's Hospital, UMCU · The Hospital for Sick Children · NCT06560606Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)
Phase 3 · Prinses Maxima Centrum Kinderoncologie · PedAL BCU, LLC · NCT05183035Treatment of Ectopic Calcification in Fahr's Disease or Syndrome
Phase 2 · University Medical Center Utrecht · UMC Utrecht · NCT05662111Head-to-Head Comparison of All Botulinum Neurotoxin Type A Products for Glabellar Rhytides
Phase 4 · Faceland · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC · NCT06448676Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiov
Phase 3 · Universitair Medisch Centrum Utrecht · Amgen · NCT07037433Study of Intravenously (IV) Infused Etentamig in Combination With an Oral Cereblon E3 Ligase Modulatory Drug (CELMoD) Ag
Phase 1 · Universitair Medisch Centrum Utrecht /ID# 267660 · AbbVie · NCT06896916A Study to Test the Safety and Effectiveness of GSK5764227, Alone or With Other Treatments, in Participants With Advance
Phase 1/Phase 2 · GSK Investigational Site · GlaxoSmithKline · NCT06885034A Prospective Study to Evaluate the Implementation of Shared Decision Making Strategy for Renal Cell Cancer (RCC)
Phase N/A · St. Antonius Hospital · NCT05548621Breast Reconstruction and Neoadjuvant Radiotherapy
NA · UMC Utrecht · NCT05216900Dietary Fiber Before Colorectal Cancer Surgery
NA · Wageningen University · NCT06212817The Radium-select Study
NA · Diakonessenhuis · The Netherlands Cancer Institute · NCT06659926A Prospective Randomised Study of Treatment Selection Based on Epigenetic Markers Versus Standard of Care Treatment Sele
NA · Universitair Medisch Centrum Utrecht · Alimentiv Inc. · NCT07363044A Study of Rapcabtagene Autoleucel in Active, Refractory Systemic Lupus Erythematosus (SLE) or Lupus Nephritis (LN) Pati
Phase 2 · Novartis Investigative Site · Novartis Pharmaceuticals · NCT06581198Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS
Phase 3 · St. Antonius Ziekenhuis, locatie Utrecht · Eli Lilly and Company · NCT06890598Combination Therapy for the Treatment of Diffuse Midline Gliomas
Phase 2 · Princess Maxima Center · University of California, San Francisco · NCT05009992Anastomotic Leakage Prevention by Endovascular Stenting of the Superior Mesenteric Artery
NA · Diakonessenhuis · Medisch Spectrum Twente · NCT07486570Preoperative CT-imaging with Patient-specific Computer Simulation in Transcatheter Aortic Valve Replacement
NA · Romy Hegeman · NCT05788770A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previ
Phase 3 · St. Antonius Ziekenhuis, locatie Utrecht · Pfizer · NCT07144280Precision Radiotherapy Using MR-linac for Pancreatic Neuroendocrine Tumours in MEN1 Patients
NA · UMC Utrecht · J.M. de Laat · NCT05037461Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcera
Phase 3 · Universitair Medisch Centrum Utrecht · Eli Lilly and Company · NCT06937086A Clinical Study to Evaluate the Effects of NXT007 Compared to Factor VIII Prophylaxis in Participants With Hemophilia A
Phase 3 · Universitair Medisch Centrum Utrecht · Hoffmann-La Roche · NCT07416526
Look up another city
Look up another condition
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.